Carregando...
ARID1A gene silencing reduces the sensitivity of ovarian clear cell carcinoma to cisplatin
In ovarian clear cell carcinoma (OCCC), the mutation rate of the AT-rich interaction domain 1A (ARID1A) gene is 46–57%. However, the effects of ARID1A gene silencing by small interfering RNA (siRNA) on the sensitivity of OCCC to cisplatin have not been investigated. Thus, this study aimed to elucida...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228580/ https://ncbi.nlm.nih.gov/pubmed/28105136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3863 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|